Review Article
Volume 16 Issue 7 - 2021
A New “Non-Epidemiological” Model of the Covid19 Pandemic - Based on Potential Infection Ceilings [Maximum Number of Infected Persons] and Blocks - Taking in to Account the Results of Simple Calculations of Virus Multiplication as Well as Infection and Infectiveness of Persons
Turski Wojciech Antoni*
Świętokrzyska [“HolyCross”] College in Kielce, Poland
*Corresponding Author: Turski Wojciech Antoni, Świętokrzyska [“HolyCross”] College in Kielce, Poland.
Received: February 15, 2021; Published: June 29, 2021




Abstract

The main objective of part I is to create of a "non-epidemiological" model of the Covid19 pandemic, or more precisely, sets of models/equations with the formulas that allow to calculate changes in pandemic parameters over time, i.e. the number of infected, sick, antibody producing ["recovered"] and dead people, based on the multiplication of viruses and the existence of ceilings and blocks for virus.

The ceilings are the maximum number of viral binding sites [SARS CoV-2] in the human body [thus related numbers of affected people] and the blocks are the viral binding sites [in the blood/extracellular space] such that viruses thus bound do not multiply [subject of separate paper sent to EC Nutrition].

This needed the introducing: a/the concept of "human breath and virus cloud" thus to move on to pandemic calculations from one person to the whole population. b/a simple arithmetic ["2x2x2..."] model/s of virus multiplication in a group of people [and so in the entire cloud]. c/Hill equation [so its constants Ka and Xmax].

Keywords: Functional Receptors for SARS-COV-2; Maximal Amount of Viruses Bound Per Person; Binding of Viruses in Blood [Block]; Duplication Time; Exponential Curves; Hill Equation; Infection; Infectivity

References

  1. Freitas Reis R., et al. “Characterization of the COVID-19 pandemic and the impact of uncertainties, mitigation strategies, and underreporting of cases in South Korea, Italy, and Brazil, Chaos Solitons Fractals 14 (2020): 109888.
  2. Ivorra B., et al. “Mathematical modeling of the spread of the coronavirus disease 2019 (COVID-19) taking into account the undetected infections. The case of China”. Communications in Nonlinear Science and Numerical Simulation 30 (2020): 105303.
  3. Pereira IG., et al. “Forecasting Covid-19 Dynamics in Brazil: A Data Driven Approach”. International Journal of Environmental Research and Public Health 14 (2020): 5115.
  4. Ndaïrou F., et al. “Mathematical Modeling of COVID-19 Transmission Dynamics with a Case Study of Wuhan”. Communications in Nonlinear Science and Numerical Simulation 30 (2020): 105303.
  5. Michael A., et al. “Delayed disease progression after allogeneic cell vaccination in hormone-resistant prostate cancer and correlation with immunologic variables”. Clinical Cancer Research 12 (2005): 4469-4478.
  6. Morgan D. “The Cell Cycle: Principles of Control. New Science Press; London, UK (2007).
  7. Ball DA., et al. “Measurement and modeling of transcriptional noise in the cell cycle regulatory network”. Cell Cycle19 (2013): 3203-3218.
  8. Drobik-Czwarno W., et al. “Identifying the genetic basis for resistance to avian influenza in commercial egg layer chickens”. Animal7 (2018): 1363-1371.
  9. T Lipniacki T., et al. “Stochastic e¤ects and bistability in T cell receptor signalling”. Journal of Theoretical Biology 254 (2008): 110-122.
  10. Turski WA. “Hypotheses on need of functional receptor system for SARS CoV-2, not just ACE2, for infectivity and on binding of SARSCoV-2 in blood mainly with serum ACE2 ,sent to EC Nutrition.
  11. Peng X., et al. “Transmission routes of 2019-nCoV and controls in dental practice”. International Journal of Oral Science 1 (2020): 9.
  12. Jasim OK., et al. “Advent of cloud computing technologies in health informatics”. International Journal “Information Theories and Applications1 (2014): 31-39.
  13. Mu RA and Hsing Kuo. “Opportunities and Challenges of Cloud Computing to Improve Health Care Services”. International Journal of Information Sciences3 (2011).
  14. Srinivasa R., et al. “Cloud computing: An overview”. Journal of Theoretical and Applied Information Technology (JATIT) (2009): 71-76.
  15. Erin Bromage, The Risks - Know Them - Avoid Them (2020).
  16. Jonathan Kay in Quillete, COVID-19 Superspreader Events in 28 Countries: Critical Patterns and Lesson (2020).
  17. Why you’re unlikely to get the coronavirus from runners or cyclists (2020).
  18. Thu Ha BT., et al. “Combating the COVID-19 Epidemic: Experiences from Vietnam”. International Journal of Environmental Research and Public Health 9 (2020): 3125.
  19. Fitzgerald DA and Wong GWK. “COVID-19: A tale of two pandemics across the Asia Pacific region”. Paediatric Respiratory Reviews 35 (2020): 75-80.
  20. Kadi N and Khelfaoui M. “Population density, a factor in the spread of COVID-19 in Algeria: statistic study”. Bulletin of the National Research Centre 1 (2020): 138.
  21. How Many Cells Are in the Human Body? Fast Facts
  22. Li M., et al. “Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues”. Infectious Diseases of Poverty 45 (2020).
  23. Sender R., et al. “The total number and mass of SARS-CoV-2 virions in an infected person”. Med Rxiv (2020): 11.16.20232009.
  24. Gooz M. “ADAM-17: The Enzyme That Does It All”. Critical Reviews in Biochemistry and Molecular Biology 45 (2010): 146-169.
  25. Hartl D., et al. “A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease”. Molecular Psychiatry 3 (2020): 629-639.
  26. Morancho B., et al. “Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence”. Breast Cancer Research 1 (2015): 106.
  27. Moss ML., et al. “Drug insight: tumor necrosis factor–converting enzyme as a pharmaceutical target for rheumatoid arthritis”. Nature Clinical Practice Rheumatology 4 (2008): 300-309.
  28. Ciaglia E., et al. “COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children, Opinion ARTICLE”. Frontiers in Pediatrics (2020).
  29. Lechien JR., et al. “ACE2 and TMPRSS2 Expressions in Head and Neck Tissues: A Systematic Review”. Head and Neck Pathology (2020): 1-11.
  30. Robinson EL., et al. “Genes encoding ACE2, TMPRSS2 and related proteins mediating SARS-CoV-2 viral entry are upregulated with age in human cardiomyocytes”. Journal of Molecular and Cellular Cardiology 147 (2020): 88-91.
  31. Schuler BA., et al. “Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 infection in the lung epithelium”. Bio Rxiv (2020).
  32. Fernández-Atucha A., et al. “Sex differences in the aging pattern of renin–angiotensin system serum peptidases”. The Biology of Sex Differences 8 (2017): 5.
  33. Dong Y., et al. “Epidemiology of COVID-19 among children in China”. Pediatrics (2020).
  34. Li Y., et al. “Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor”. Pharmacological Research 157 (2020): 104833.
  35. Schultze B., et al. “The S protein of bovine coronavirus is a hemagglutinin recognizing 9-O-acetylated sialic acid as a receptor determinant”. Journal of Virology 11 (1991): 6232-6237.
  36. Deleers M., et al. “Covid-19 and blood groups: ABO antibody levels may also matter [published online ahead of print, 2020 Dec 14]”. International Journal of Infectious Diseases 104 (2020): 242-249.
  37. Bank Eric. "How Much Time Does It Take for a DNA Molecule to Replicate?" sciencing.com (2021).
  38. Darzacq X., et al. “In vivo dynamics of RNA polymerase II transcription”. Nature Structural and Molecular Biology 9 (2007): 796-806.
  39. Fung A., et al. “Efficiency of incorporation and chain termination determines the inhibition potency of 2'-modified nucleotide analogs against hepatitis C virus polymerase”. Antimicrobial Agents and Chemotherapy 58 (2014): 3636-3645.
  40. Canini L and Perelson AS. “Viral Kinetic Modeling: State of the Art”. Journal of Pharmacokinetics and Pharmacodynamics 5 (2014): 431-443.
  41. O’Brien A., et al. “Characterizing replication kinetics and plaque production of type I feline infectious peritonitis virus in three feline cell lines”. Virology 525 (2018): 1-9.
  42. Timm A and Yin J. “Kinetics of virus production from single cells”. Virology1 (2012): 11-17.
  43. Whalley SA., et al. “Kinetics of Acute Hepatitis B Virus Infection in Humans”. Journal of Experimental Medicine 7 (2001): 847-854.
  44. Graw F and Perelson AS. “Modeling Viral Spread”. Annual Review of Virology 1 (2016): 555-572.
  45. Domingo E. “Interaction of Virus Populations with Their Hosts”. Virus as Populations (2016): 123-168.
  46. Vitiello A and Ferrara F. “Colchicine and SARS-CoV-2: Management of the hyperinflammatory state”. Respiratory Medicine 178 (2021): 106322.
  47. Wang JJ., et al. “Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities”. Pharmacology and Therapeutics 215 (2020): 107628.
  48. Kuba K., et al. “Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters”. Pharmacology and Therapeutics1 (2010): 119-128.
  49. Piyush R., et al. “Nucleic acid-based therapy for coronavirus disease 2019”. Heliyon 9 (2020): e05007.
  50. Kumar M., et al. “Decoding the silent walk of COVID-19: Halting its spread using old bullets”. Biomedicine and Pharmacotherapy 133 (2021): 110891.
  51. Kanherkar RR., et al. “Cellular reprogramming for understanding and treating human disease”. Frontiers in Cell and Developmental Biology 2 (2014): 67.
  52. Gesztelyi Rudolf., et al. “The Hill equation and the origin of quantitative pharmacology". Archive for History of Exact Sciences4 (2012): 427-438.
  53. Weiss JN. "The Hill equation revisited: uses and misuses". The FASEB Journal11 (1997): 835-841.
  54. Srinivasan Bharath. "Explicit Treatment of Non Michaelis-Menten and Atypical Kinetics in Early Drug Discovery". dx.doi.org. Retrieved (2020).
  55. Vandenberg LN., et al. “Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses". Endocrine Reviews 3 (2012): 378-455.
  56. Goutelle Sylvain., et al. “The Hill equation: a review of its capabilities in pharmacological modelling". The Pharmacy Integration Fund 6 (2008): 633-648.
  57. Colquhoun D (2006). "The quantitative analysis of drug-receptor interactions: a short history". Trends in Pharmacological Sciences 3 (2006): 149-157.
  58. Exposure-Response Relationships - Study Design, Data Analysis, and Regulatory Applications, (PDF). (2019).
  59. Dixon M,Webb E,[ass Thorne CJR,Tipton KF]: The Enzymes,Third ed.,Longman,New York (1979).
  60. Zhu N., et al. “A Novel Coronavirus from Patients with Pneumonia in China, 2019”. The New England Journal of Medicine 38238 (2020): 727-733.
  61. Amarante-Mendes GP., et al. “Pattern Recognition Receptors and the Host Cell Death Molecular Machinery”. Frontiers in Immunology 9 (2018): 2379.
  62. Tang T., et al. “Coronavirus membrane fusion mechanism offers a potential target for antiviral development”. Antiviral Research 178 (2020): 104792.
  63. Schäuble S., et al. “Effect of substrate competition in kinetic models of metabolic network”. FEBS Letters17 (2013): 2818-2824.
  64. Mackay D. “An analysis of functional antagonism and synergism Mackay D, Br”. Journal of Pharmaceutics 73 (1981): 127-134.
  65. Sun J., et al. “Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids”. Emerging Infectious Diseases 8 (2020): 1834-1838.
  66. Leroy H., et al. “Virus-Mediated Cell-Cell Fusion”. International Journal of Molecular Sciences 24 (2020): 9644.
Citation: Turski Wojciech Antoni. “A New “Non-Epidemiological” Model of the Covid19 Pandemic - Based on Potential Infection Ceilings [Maximum Number of Infected Persons] and Blocks - Taking in to Account the Results of Simple Calculations of Virus Multiplication as Well as Infection and Infectiveness of Persons”. EC Nutrition 16.7 (2021): 32-60.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


January Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before February 14, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.